Insufficient scRNA-seq data for expression of B4GALNT2 at single-cell level.
Insufficient scRNA-seq data for expression of B4GALNT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 459.78 | 89 / 89 | 41% | 3.11 | 370 / 901 |
| thymus | 99% | 478.92 | 644 / 653 | 31% | 1.44 | 186 / 605 |
| stomach | 75% | 731.94 | 269 / 359 | 20% | 1.92 | 57 / 286 |
| intestine | 53% | 1569.36 | 510 / 966 | 32% | 2.64 | 171 / 527 |
| skin | 48% | 93.04 | 873 / 1809 | 1% | 0.04 | 3 / 472 |
| lung | 12% | 7.87 | 67 / 578 | 26% | 2.19 | 299 / 1155 |
| adrenal gland | 34% | 41.42 | 89 / 258 | 1% | 0.24 | 3 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 2.15 | 12 / 45 |
| liver | 0% | 0 | 0 / 226 | 26% | 1.92 | 106 / 406 |
| breast | 5% | 6.10 | 21 / 459 | 20% | 1.96 | 222 / 1118 |
| esophagus | 5% | 2.95 | 67 / 1445 | 14% | 1.34 | 26 / 183 |
| uterus | 0% | 0 | 0 / 170 | 18% | 1.31 | 82 / 459 |
| bladder | 0% | 0 | 0 / 21 | 16% | 1.53 | 80 / 504 |
| pancreas | 0% | 0 | 0 / 328 | 6% | 0.87 | 10 / 178 |
| ovary | 0% | 0 | 0 / 180 | 3% | 0.06 | 14 / 430 |
| brain | 1% | 0.79 | 19 / 2642 | 0% | 0.00 | 1 / 705 |
| prostate | 1% | 0.54 | 2 / 245 | 0% | 0 | 0 / 502 |
| adipose | 0% | 0.31 | 3 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.07 | 1 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.13 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
| GO_0043403 | Biological process | skeletal muscle tissue regeneration |
| GO_0006047 | Biological process | UDP-N-acetylglucosamine metabolic process |
| GO_0017038 | Biological process | protein import |
| GO_0009312 | Biological process | oligosaccharide biosynthetic process |
| GO_0030259 | Biological process | lipid glycosylation |
| GO_0098528 | Biological process | skeletal muscle fiber differentiation |
| GO_0019276 | Biological process | UDP-N-acetylgalactosamine metabolic process |
| GO_0022408 | Biological process | negative regulation of cell-cell adhesion |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0008376 | Molecular function | acetylgalactosaminyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | B4GALNT2 |
| Protein name | Beta-1,4 N-acetylgalactosaminyltransferase 2 (EC 2.4.1.-) (Sd(a) beta-1,4-GalNAc transferase) (UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase) |
| Synonyms | GALGT2 |
| Description | FUNCTION: Involved in the synthesis of the Sd(a) antigen (Sia-alpha2,3-[GalNAc-beta1,4]Gal-beta1,4-GlcNAc), a carbohydrate determinant expressed on erythrocytes, the colonic mucosa and other tissues. Transfers a beta-1,4-linked GalNAc to the galactose residue of an alpha-2,3-sialylated chain. . |
| Accessions | ENST00000300404.2 [Q8NHY0-1] Q8NHY0 ENST00000393354.7 [Q8NHY0-2] ENST00000504681.5 [Q8NHY0-3] |